128 related articles for article (PubMed ID: 1490576)
1. [Use of desferal in anemia, myeloid leukemia and other pathological conditions].
Kol'tsova GN; Meshchanov AIu
Gematol Transfuziol; 1992; 37(9-10):44-6. PubMed ID: 1490576
[No Abstract] [Full Text] [Related]
2. Desferal therapy in iron storage disease.
Thompson RB; Owen DM; Bell WN
Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
[No Abstract] [Full Text] [Related]
3. [Use of desferal and some data on hemosiderosis in hypo- and aplastic anemias].
Fainshtein FE; Trubina NS; Sobaleva IuG; Rozanova NS; Voronina AN
Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):31-8. PubMed ID: 5736846
[No Abstract] [Full Text] [Related]
4. [Treatment of primary idiopathic hemochromatosis and secondary hemosiderosis].
Strohmeyer G
Dtsch Med Wochenschr; 1974 Nov; 99(45):2295-9. PubMed ID: 4448138
[No Abstract] [Full Text] [Related]
5. The treatment of hemosiderosis in thalassaemia major with desferrioxamine-B.
Kirimlidis S; Philippidis P; Drossos C; Economidis J
Helv Paediatr Acta; 1966 Sep; 21(4):343-50. PubMed ID: 5997620
[No Abstract] [Full Text] [Related]
6. [Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia].
Cario H; Grosse R; Janssen G; Jarisch A; Meerpohl J; Strauss G;
Klin Padiatr; 2010 Nov; 222(6):399-406. PubMed ID: 20862634
[TBL] [Abstract][Full Text] [Related]
7. [Desferrioxamine in patients with hemochromatosis and hemosiderosis].
Maspes V; Tamigaki M; Gomes ZJ; Jamra M
Rev Hosp Clin Fac Med Sao Paulo; 1966; 21(4):181-95. PubMed ID: 5918167
[No Abstract] [Full Text] [Related]
8. [Use of desferal in treatment of sideroses of different origin. (Literature review)].
Turbina NS
Probl Gematol Pereliv Krovi; 1968 Jul; 13(7):47-52. PubMed ID: 4898933
[No Abstract] [Full Text] [Related]
9. [Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].
Cartei G; Cazzavillan M; Chisesi T; Battista R; Barbui T; Dini E
Minerva Med; 1978 Mar; 69(13):811-21. PubMed ID: 643223
[No Abstract] [Full Text] [Related]
10. [Use of desferrioxamine B in normal subjects and in patients with increased iron storage].
Muranda M; Velasco M; Giménez E; Ruiz J; Bastías E; Rodriguez J; Etcheverry R; Guzmán C; Regonesi C; Janklevich S
Rev Med Chil; 1965 Apr; 93(4):127-33. PubMed ID: 5832943
[No Abstract] [Full Text] [Related]
11. [Therapeutic results in the treatment of primary and secondary hemochromatoses with Desferal].
Wöhler F
Blut; 1967 Apr; 15(1):33-42. PubMed ID: 6025965
[No Abstract] [Full Text] [Related]
12. Effect of phenylhydrazine-induced haemolysis on the urinary excretion of iron after desferrioxamine.
Cumming RL; Goldberg A; Morrow J; Smith JA
Lancet; 1967 Jan; 1(7481):71-4. PubMed ID: 4163055
[No Abstract] [Full Text] [Related]
13. [Deferoxamine-B, a ferriuretic chelate].
Dyerberg J
Ugeskr Laeger; 1967 Sep; 129(36):1135-9. PubMed ID: 4880917
[No Abstract] [Full Text] [Related]
14. Iron chelation in acute iron poisoning and chronic hypersiderosis.
Walsh JR; Gillick JB
Clin Pediatr (Phila); 1965 Nov; 4(11):633-8. PubMed ID: 5844429
[No Abstract] [Full Text] [Related]
15. Chelation therapy for iron overload.
Nutr Rev; 1980 May; 38(5):185-7. PubMed ID: 7207885
[No Abstract] [Full Text] [Related]
16. Iron metabolism and chelation therapy in hemosiderosis.
Graziano JH
Curr Top Hematol; 1978; 1():127-50. PubMed ID: 400529
[No Abstract] [Full Text] [Related]
17. Iron overload? In sickle cell disease?
Day S; Dancy R; Kelly K; Wang W
MCN Am J Matern Child Nurs; 1993; 18(6):330-5. PubMed ID: 8295522
[No Abstract] [Full Text] [Related]
18. [Desferal therapy of hemosiderosis in patients with hemoglobinopathies].
Khutsishvilĭ GE; Orlova LD; Iusuf AM
Probl Gematol Pereliv Krovi; 1970 Mar; 15(3):60-2. PubMed ID: 5449830
[No Abstract] [Full Text] [Related]
19. [Treatment of post-transfusion iron overload by deferoxamine].
de Montalembert M; Llados A; Hannedouche T; Girot R
Arch Fr Pediatr; 1989 Feb; 46(2):99-105. PubMed ID: 2735804
[TBL] [Abstract][Full Text] [Related]
20. [A new iron chelating agent: desferrioxamine B (Desferal). Clinico-pharmacological observations. Cases].
Gallinelli R; Coppini D
Minerva Med; 1965 Nov; 56(92):3980-5. PubMed ID: 5845686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
